Discover the Top Companies in the Spinal Laminoplasty Market

The global spinal laminoplasty market was valued at USD 8.03 billion in 2023, driven by the rising prevalence of spinal disorders and advancements in minimally invasive surgical techniques across the globe. The market is expected to grow at a CAGR of 4.62% during the forecast period of 2024-2032, with the values likely to reach USD 12.18 billion by 2032.

Spinal laminoplasty is a procedure that is performed on the spinal bones to treat spinal cord compression. This specialized procedure opens the spinal canal via the lamina bone and aids in relieving pressure on the spinal cord. Spinal laminoplasty is commonly indicated for cervical spondylotic myelopathy, multilevel spinal stenosis, and traumatic injuries that result in severe spinal cord compression in the cervical spine.

The increasing cases of these spinal conditions along with the growing aging population and sedentary lifestyles are significantly contributing to the market demand for spinal laminoplasty. The development of new laminoplasty procedures along with the rising innovations in minimally invasive surgical techniques are elevating the market value. Laminectomy with fusion (LF) along with spinal laminoplasty (LP) is a common posterior decompression practice performed to treat multilevel degenerative cervical myelopathy (DCM). However, the success rates and cost-effectiveness of LP are high in comparison of LF. Moreover, the rising incidence of spinal cord injuries  and the expansion of specialized surgical centres are contributing to the increased demand expected to shape the market landscape.

The market is experiencing rising demand for minimally invasive spine surgeries due to the growing technical advancements and geriatric population. With an increasing demand for minimally invasive procedures, the requirement for improvements in precision devices used in minimally invasive procedures has also risen, propelling the market growth. The market players are focusing on bringing improved laminoplasty systems to the market. For instance, in November 2023, Curiteva, a privately held technology and manufacturing company introduced its Prowess Laminoplasty System commercially. The system is designed to provide surgeons with tools that offer greater precision, accuracy, and efficiency for performing posterior decompression of the cervical spine.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top Companies Leading the Spinal Laminoplasty Market in 2024

1.    DePuy Synthes, Inc. (Johnson & Johnson Services, Inc.)

DePuy Synthes, a subsidiary of Johnson & Johnson, is a leading player in the spinal laminoplasty market. The company offers a range of spinal surgery solutions, including advanced implants and instruments specifically designed for laminoplasty procedures. DePuy has various products dedicated to precision and reliability used in procedures such as cervical myelopathy and spinal stenosis.

2.    Medtronic plc

Headquartered in Dublin, Ireland, Medtronic is one of the largest medical device companies in the world. Their product portfolio covers various medical domains including cardiac and vascular devices, minimally invasive therapies, restorative therapies, and diabetes. The company’s active participation in research development activities toward advancements in spinal surgeries through heavy investments is a major contribution showcasing commitment to improving the domain.

3.    NuVasive Inc.

NuVasive Inc. specializes in minimally invasive surgical solutions, including spinal laminoplasty. The company’s portfolio includes advanced implants and instruments that enable surgeons to perform precise spinal decompressions and stabilizations. By providing comprehensive solutions for spinal laminoplasty, NuVasive helps improve patient outcomes and recovery times, making significant contributions to the field of spinal surgery.

4.    Zimmer Biomet

Zimmer Biomet is a leading medical device company with a strong presence in the spinal laminoplasty market. The company offers a range of implants and surgical instruments designed for spinal decompression and stabilization. Zimmer Biomet’s products are engineered to provide precision and reliability during laminoplasty procedures, helping to address conditions such as spinal stenosis and myelopathy. By focusing on innovative solutions and surgeon education, Zimmer Biomet strives to improve surgical outcomes and patient recovery, reinforcing its leadership in spinal healthcare.

5.    Stryker

It is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company has an impressive portfolio across different areas of healthcare including implants used in joint replacement and trauma surgeries along with surgical equipment and surgical navigation systems. It also includes endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular, and spinal devices and other medical device products. The company contributes continuously through its innovations in the domain and by participating in research and development activities.

6.    Globus Medical

Globus Medical is a leading developer of innovative spinal implants and instruments, including solutions for laminoplasty procedures. The company’s products are designed to provide precision and reliability during spinal decompression and stabilisation surgeries. Globus Medical focuses on advanced technologies and minimally invasive approaches with an aim to improve patient outcomes and reduce recovery times for spinal surgeries.

7.    B. Braun SE

B. Braun S E is a global healthcare company that provides a wide range of medical devices, including spinal implants and instruments for laminoplasty procedures. The company has expertise in spinal laminoplasty equipment and has an impressive portfolio that includes products designed to ensure precision, and safety during spinal decompressions and stabilizations.